drug · small molecule
patient view →apatinib mesylate
pre_registrationupdated 2mo agoby Elevar Therapeutics Inc🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for breast cancer and 17 investigational indications.
targets
Vascular endothelial growth factor receptor 2
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that